FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376642685> ?p ?o ?g. }

• W4376642685 abstract "Background Heparin anticoagulation (HA) is commonly employed for membrane therapeutic plasma exchange (mTPE). However, for patients with increased bleeding risk, there were controversial opinions on the use of HA versus regional citrate anticoagulation (RCA) for mTPE. Our present study aimed to evaluate the efficacy and safety of HA vs. RCA for mTPE in patients with increased bleeding risk.Methods Patients with increased bleeding risk who underwent mTPE between 2014 and 2021 in our center were screened. Observations of anticoagulation efficacy and safety were used as the study endpoints.Results A total of 108 patients with 368 mTPE sessions were included. Of the included patients, 38 and 70 received HA and RCA mTPE, respectively. There was no significant difference in the clotting of extracorporeal circuits between the HA and RCA groups (4.1% vs. 4.4%, p = 0.605). More bleeding episodes were observed in the HA group compared to the RCA group (16.4% vs. 4.4% mTPE sessions, p < 0.001). The frequency of postoperative transfusion within 24 h (11% vs. 3.4%, p = 0.007) was significantly different in the HA and RCA group. Anticoagulation strategy (HA vs. RCA; OR 5.659, 95%CI 2.266-14.129; p < 0.001), and mean arterial pressure (prior treatment, OR 1.052, 95%CI 1.019-1.086; p = 0.002) were independent risk factors of bleeding episodes. At the end of mTPE treatment, the incidence of metabolic alkalosis (16.7% vs. 54.1%, p = 0.027) and hypocalcemia (41.7% vs. 89.2%, p = 0.001) was significantly different in the HA (n = 5, 12 sessions) and RCA (n = 22, 74 sessions) groups, respectively.Conclusion RCA is as effective as HA for mTPE. However, for patients with increased bleeding risk, RCA is associated with a lower risk of bleeding, compared with HA. With careful monitoring and timely adjustment, RCA most likely is a safe and effective anticoagulation option for mTPE in patients with increased bleeding risk." @default.
• W4376642685 created "2023-05-17" @default.
• W4376642685 creator A5013520470 @default.
• W4376642685 creator A5018860616 @default.
• W4376642685 creator A5032344597 @default.
• W4376642685 creator A5037792674 @default.
• W4376642685 creator A5038549808 @default.
• W4376642685 creator A5050189110 @default.
• W4376642685 creator A5056073947 @default.
• W4376642685 creator A5060431284 @default.
• W4376642685 creator A5069504454 @default.
• W4376642685 creator A5087484823 @default.
• W4376642685 date "2023-05-15" @default.
• W4376642685 modified "2023-09-27" @default.
• W4376642685 title "Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk" @default.
• W4376642685 cites W147166911 @default.
• W4376642685 cites W1521836859 @default.
• W4376642685 cites W1537468785 @default.
• W4376642685 cites W1685331907 @default.
• W4376642685 cites W1798010974 @default.
• W4376642685 cites W1998339640 @default.
• W4376642685 cites W2004142466 @default.
• W4376642685 cites W2012078870 @default.
• W4376642685 cites W2026274122 @default.
• W4376642685 cites W2032786427 @default.
• W4376642685 cites W2043098061 @default.
• W4376642685 cites W2050540458 @default.
• W4376642685 cites W2058392039 @default.
• W4376642685 cites W2067658907 @default.
• W4376642685 cites W2076330369 @default.
• W4376642685 cites W2079845753 @default.
• W4376642685 cites W2096192748 @default.
• W4376642685 cites W2101501796 @default.
• W4376642685 cites W2154779047 @default.
• W4376642685 cites W2160274305 @default.
• W4376642685 cites W2161396644 @default.
• W4376642685 cites W2167157956 @default.
• W4376642685 cites W2309736365 @default.
• W4376642685 cites W2336734636 @default.
• W4376642685 cites W2562341973 @default.
• W4376642685 cites W2612704463 @default.
• W4376642685 cites W2626054796 @default.
• W4376642685 cites W2768801834 @default.
• W4376642685 cites W2792289376 @default.
• W4376642685 cites W2894901557 @default.
• W4376642685 cites W2947461022 @default.
• W4376642685 cites W2952094345 @default.
• W4376642685 cites W3012321385 @default.
• W4376642685 cites W3016908366 @default.
• W4376642685 cites W3023569947 @default.
• W4376642685 cites W3046357556 @default.
• W4376642685 cites W3080736968 @default.
• W4376642685 cites W3145717665 @default.
• W4376642685 cites W4200462421 @default.
• W4376642685 cites W4206360499 @default.
• W4376642685 cites W4242966060 @default.
• W4376642685 cites W4283166520 @default.
• W4376642685 cites W4290975588 @default.
• W4376642685 doi "https://doi.org/10.1080/0886022x.2023.2210691" @default.
• W4376642685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37183868" @default.
• W4376642685 hasPublicationYear "2023" @default.
• W4376642685 type Work @default.
• W4376642685 citedByCount "0" @default.
• W4376642685 crossrefType "journal-article" @default.
• W4376642685 hasAuthorship W4376642685A5013520470 @default.
• W4376642685 hasAuthorship W4376642685A5018860616 @default.
• W4376642685 hasAuthorship W4376642685A5032344597 @default.
• W4376642685 hasAuthorship W4376642685A5037792674 @default.
• W4376642685 hasAuthorship W4376642685A5038549808 @default.
• W4376642685 hasAuthorship W4376642685A5050189110 @default.
• W4376642685 hasAuthorship W4376642685A5056073947 @default.
• W4376642685 hasAuthorship W4376642685A5060431284 @default.
• W4376642685 hasAuthorship W4376642685A5069504454 @default.
• W4376642685 hasAuthorship W4376642685A5087484823 @default.
• W4376642685 hasBestOaLocation W43766426851 @default.
• W4376642685 hasConcept C120665830 @default.
• W4376642685 hasConcept C121332964 @default.
• W4376642685 hasConcept C126322002 @default.
• W4376642685 hasConcept C141071460 @default.
• W4376642685 hasConcept C2777015399 @default.
• W4376642685 hasConcept C2777557582 @default.
• W4376642685 hasConcept C2777987278 @default.
• W4376642685 hasConcept C2779539245 @default.
• W4376642685 hasConcept C2780073493 @default.
• W4376642685 hasConcept C42219234 @default.
• W4376642685 hasConcept C61511704 @default.
• W4376642685 hasConcept C71924100 @default.
• W4376642685 hasConceptScore W4376642685C120665830 @default.
• W4376642685 hasConceptScore W4376642685C121332964 @default.
• W4376642685 hasConceptScore W4376642685C126322002 @default.
• W4376642685 hasConceptScore W4376642685C141071460 @default.
• W4376642685 hasConceptScore W4376642685C2777015399 @default.
• W4376642685 hasConceptScore W4376642685C2777557582 @default.
• W4376642685 hasConceptScore W4376642685C2777987278 @default.
• W4376642685 hasConceptScore W4376642685C2779539245 @default.
• W4376642685 hasConceptScore W4376642685C2780073493 @default.
• W4376642685 hasConceptScore W4376642685C42219234 @default.
• W4376642685 hasConceptScore W4376642685C61511704 @default.
• W4376642685 hasConceptScore W4376642685C71924100 @default.
• W4376642685 hasIssue "1" @default.

• next